Gotowa bibliografia na temat „Small Cell Lung Cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Small Cell Lung Cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Small Cell Lung Cancer"
Greschuchna, D. "Surgical Treatment of Small Cell Lung Cancer". Journal of the Japanese Association for Chest Surgery 3, nr 2 (1989): 169. http://dx.doi.org/10.2995/jacsurg1987.3.2_169.
Pełny tekst źródła_, _. "Small Cell Lung Cancer". Journal of the National Comprehensive Cancer Network 6, nr 3 (marzec 2008): 294. http://dx.doi.org/10.6004/jnccn.2008.0025.
Pełny tekst źródłaHellriegel, H. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY". Siberian Medical Review, nr 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-12.
Pełny tekst źródłaKlaus-Peter, K. "ADVANCED NON-SMALL-CELL LUNG CANCER. THE SIGNIFICANCE OF PERSONALIZED THERAPY". Siberian Medical Review, nr 6 (2017): 6–12. http://dx.doi.org/10.20333/2500136-2017-6-6-12.
Pełny tekst źródłaKalemkerian, Gregory P., Wallace Akerley, Paul Bogner, Hossein Borghaei, Laura Chow, Robert J. Downey, Leena Gandhi i in. "Small Cell Lung Cancer". Journal of the National Comprehensive Cancer Network 9, nr 10 (październik 2011): 1086–113. http://dx.doi.org/10.6004/jnccn.2011.0092.
Pełny tekst źródłaKalemkerian, Gregory P., Wallace Akerley, Paul Bogner, Hossein Borghaei, Laura QM Chow, Robert J. Downey, Leena Gandhi i in. "Small Cell Lung Cancer". Journal of the National Comprehensive Cancer Network 11, nr 1 (styczeń 2013): 78–98. http://dx.doi.org/10.6004/jnccn.2013.0011.
Pełny tekst źródłaByrne, Bernadette. "Small cell lung cancer". Nursing Standard 8, nr 9 (23.11.1993): 23–28. http://dx.doi.org/10.7748/ns.8.9.23.s42.
Pełny tekst źródłaHinson, J. A., i M. C. Perry. "Small cell lung cancer". CA: A Cancer Journal for Clinicians 43, nr 4 (1.07.1993): 216–25. http://dx.doi.org/10.3322/canjclin.43.4.216.
Pełny tekst źródłaBakhmutsky, Nicolay G., Vladimir A. Porkhanov, Vadim N. Bodnya i Rostislav P. Schiryayev. "Small-cell lung cancer". Medical Herald of the South of Russia 8, nr 4 (1.01.2017): 6–13. http://dx.doi.org/10.21886/2219-8075-2017-8-4-6-13.
Pełny tekst źródłaSher, Taimur, Grace K. Dy i Alex A. Adjei. "Small Cell Lung Cancer". Mayo Clinic Proceedings 83, nr 3 (marzec 2008): 355–67. http://dx.doi.org/10.4065/83.3.355.
Pełny tekst źródłaRozprawy doktorskie na temat "Small Cell Lung Cancer"
Sarvi, Sana. "Small cell lung cancer and cancer stem cell-like cells". Thesis, University of Edinburgh, 2014. http://hdl.handle.net/1842/9542.
Pełny tekst źródłaKapeleris, Joanna C. "Circulating tumour cells in non-small cell lung cancer". Thesis, Queensland University of Technology, 2022. https://eprints.qut.edu.au/228607/1/Joanna_Kapeleris_Thesis.pdf.
Pełny tekst źródłaWang, Wei. "Modulation of immune cell responses by small cell lung cancer cells". Thesis, King's College London (University of London), 2016. https://kclpure.kcl.ac.uk/portal/en/theses/modulation-of-immune-cell-responses-by-small-cell-lung-cancer-cells(7bdc85c2-acd8-4f13-9d2b-e2ce07d1567b).html.
Pełny tekst źródłaOosterhout, Anselmus Gerardus Maria van. "Small cell lung cancer and brain metastasis". Maastricht : Maastricht : Rijksuniversiteit Limburg ; University Library, Maastricht University [Host], 1995. http://arno.unimaas.nl/show.cgi?fid=6643.
Pełny tekst źródłaSeute, Tatjana. "Neurologic complications in small cell lung cancer". Maastricht : Maastricht : Universiteit Maastricht ; University Library, Universiteit Maastricht [host], 2008. http://arno.unimaas.nl/show.cgi?fid=9520.
Pełny tekst źródłaMacaulay, Valentine. "Growth regulation in small cell lung cancer". Thesis, Imperial College London, 1989. http://hdl.handle.net/10044/1/47547.
Pełny tekst źródłaSikkink, Stephen K. "Genetic pathology of non-small cell lung cancer". Thesis, University of Liverpool, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.250405.
Pełny tekst źródłaBrena, Romulo Martin. "Aberrant DNA methylation in human non-small cell lung cancer". Columbus, Ohio : Ohio State University, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1172083621.
Pełny tekst źródłaWong, Wing-sze, i 黃詠詩. "Fusion genes in non-small cell lung cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43781378.
Pełny tekst źródłaNg, Sheng Rong. "CRISPR-mediated interrogation of small cell lung cancer". Thesis, Massachusetts Institute of Technology, 2018. http://hdl.handle.net/1721.1/117782.
Pełny tekst źródłaThis electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.
Cataloged student-submitted from PDF version of thesis. Vita.
Includes bibliographical references.
Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine lung carcinoma that remains among the most lethal of solid tumor malignancies. Despite decades of research, treatment outcomes for SCLC remain very poor, highlighting the need for novel approaches to target the disease. Recent genomic sequencing studies have identified multiple recurrently altered genes in human SCLC tumors, many of which remain to be functionally validated. Genetically engineered mouse models (GEMMs) of SCLC have been developed that recapitulate many key features of human SCLC. These models have been used extensively to investigate various aspects of SCLC biology, including tumor initiation, progression and metastasis. The development of the CRISPR-Cas9 system has greatly facilitated genome editing in mammalian cells, leading to its widespread adoption for various applications in cancer biology. We have utilized this system in two complementary ways to investigate the molecular mechanisms involved in SCLC initiation, progression and maintenance. Firstly, we have adapted the CRISPR-Cas9 system for use in GEMMs of SCLC, to enable rapid modeling and functional validation of candidate tumor suppressor genes in vivo. Using this system, we have demonstrated that p107, a member of the retinoblastoma family that is mutated in a significant fraction of human SCLC tumors, is a functional tumor suppressor in SCLC. Notably, loss of p107 in SCLC tumors resulted in significant phenotypic differences compared with loss of its close relative, p130. We also demonstrated that CRISPR-induced mutations can be used to infer lineage relationships between primary and metastatic tumors in the same animal. Secondly, we have performed a CRISPR-based genetic screen, utilizing a custom sgRNA library targeting the druggable genome, to identify novel SCLC-specific genetic vulnerabilities. We found that SCLC cells displayed enhanced sensitivity towards disruption of several key metabolic pathways, including the de novo pyrimidine biosynthesis pathway. Pharmacological inhibition of Dhodh, a key enzyme in this pathway, reduced the viability of SCLC cells in vitro and strongly suppressed SCLC tumor growth in vivo, validating this pathway as a promising therapeutic target in SCLC. Taken together, the work presented here demonstrates the utility of the CRISPR-Cas9 system for performing functional interrogation of SCLC.
by Sheng Rong Ng.
Ph. D.
Książki na temat "Small Cell Lung Cancer"
Seeber, Siegfried, red. Small Cell Lung Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-82372-5.
Pełny tekst źródłaRamaswamy, Govindan, red. Locally advanced non-small-cell lung cancer. Manhasset, NY: CMP United Business Media, 2004.
Znajdź pełny tekst źródłaCarr, David T. Selected abstracts on small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.
Znajdź pełny tekst źródła1935-, Skarin Arthur T., i Alexander Eben, red. Multimodality treatment of lung cancer. New York: M. Dekker, 2000.
Znajdź pełny tekst źródłaGovindan, Ramaswamy. Recent advances in locally advanced non-small-cell lung cancer. Manhasset, N.Y: CMPMedica, 2006.
Znajdź pełny tekst źródłaIASLC Workshop on Small Cell Lung Cancer (3rd 1989 Helsingør, Denmark). Management of small cell lung cancer: Third IASLC Workshop on Small Cell Lung Cancer, Elsinore, Denmark, 18-22 June, 1989. Redaktorzy Hansen Heine Høi, Kristjansen Paul E. G i International Association for the Study of Lung Cancer. Amsterdam: Elsevier, 1989.
Znajdź pełny tekst źródłaM, Marangolo, i Fiorentini G, red. Small cell lung cancer: Proceedings of the International Conference on Small Cell Lung Cancer, 27-28 March 1987, Ravenna, Italy. Oxford: Pergamon Press, 1988.
Znajdź pełny tekst źródłaInternational Workshop on Small Cell Lung Cancer Antigens (2nd 1990 Royal Society of Medicine). Small cell lung cancer antigens: Proceedings of the Second International Workshop on Small Cell Lung Cancer Antigens held at the Royal Society of Medicine, 25-27 April 1990. [Basingstoke, Hampshire: published for Cancer Research Campaign by Macmillan, 1991.
Znajdź pełny tekst źródłaSmall cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.
Znajdź pełny tekst źródłaEttinger, David S. The role of chemotherapy in non-small cell lung cancer. Syracuse, NY: Bristol Laboratories Oncology Products, Bristol-Myers Oncology Division, 1986.
Znajdź pełny tekst źródłaCzęści książek na temat "Small Cell Lung Cancer"
Ravenel, James G. "Small Cell Carcinoma". W Lung Cancer Imaging, 79–88. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-60761-620-7_7.
Pełny tekst źródłaMunden, Reginald F., i Jeremy J. Erasmus. "Thoracic Imaging Techniques for Non-Small Cell and Small Cell Lung Cancer". W Lung Cancer, 35–56. New York, NY: Springer New York, 2003. http://dx.doi.org/10.1007/0-387-22652-4_3.
Pełny tekst źródłaHansen, Heine H. "Small Cell Lung Cancer Treatment". W Lung Cancer, 44–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-76031-0_20.
Pełny tekst źródłaHanrahan, Emer O., i Bonnie Glisson. "Small Cell Carcinoma of the Lung". W Lung Cancer, 395–434. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-524-8_16.
Pełny tekst źródłaHann, Christine L. "Small Cell Lung Cancer: Biology Advances". W Lung Cancer, 197–211. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-74028-3_9.
Pełny tekst źródłaGomez, Daniel, Zhongxing Liao, Pierre Saintigny i Ritsuko U. Komaki. "Combinations of Radiation Therapy and Chemotherapy for Non-Small Cell and Small-Cell Lung Carcinoma". W Lung Cancer, 353–78. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2014. http://dx.doi.org/10.1002/9781118468791.ch23.
Pełny tekst źródłaGadgeel, Shirish. "Small Cell Lung Cancer". W Encyclopedia of Cancer, 1–6. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_6764-2.
Pełny tekst źródłaGadgeel, Shirish. "Small Cell Lung Cancer". W Encyclopedia of Cancer, 4261–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-46875-3_6764.
Pełny tekst źródłaGadgeel, Shirish. "Small Cell Lung Cancer". W Encyclopedia of Cancer, 3444–48. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_6764.
Pełny tekst źródłaWahl, Michael, i Adam Garsa. "Small Cell Lung Cancer". W Handbook of Evidence-Based Radiation Oncology, 285–91. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62642-0_14.
Pełny tekst źródłaStreszczenia konferencji na temat "Small Cell Lung Cancer"
Patel, Sagar S., Ramesh Natarajan i Rebecca L. Heise. "Mechanotransduction of Primary Cilia in Lung Adenocarcinoma". W ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80435.
Pełny tekst źródłaBenammar, Sarra, Fatima Mraiche, Jensa Mariam Joseph i Katerina Gorachinova. "Glucose and Transferrin Liganded PLGA Nanoparticles Internalization in Non-Small Lung Cancer Cells". W Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0227.
Pełny tekst źródłaHider, Nabilah Hanani, Anis Salwa Binti Mohd Khairuddin i Effariza Binti Hanafi. "VGG Classification Model for Lung Cancer Diagnosis". W International Technical Postgraduate Conference 2022. AIJR Publisher, 2022. http://dx.doi.org/10.21467/proceedings.141.9.
Pełny tekst źródłaJabbour, E., P. Sidhom i R. El-Bizri. "Small Cell Lung Cancer, Does It Cavitate". W American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7012.
Pełny tekst źródłaXing, Fuyong, i Lin Yang. "Robust cell segmentation for non-small cell lung cancer". W 2013 IEEE 10th International Symposium on Biomedical Imaging (ISBI 2013). IEEE, 2013. http://dx.doi.org/10.1109/isbi.2013.6556493.
Pełny tekst źródłaHamedi, Z., S. Kamboj, S. Kumar, R. A. Jiwani i N. Sharma. "Transformation of Non-Small Cell Lung Cancer (NSCLC) to Small Cell Lung Cancer (SCLC), Mechanism of Treatment Resistance?" W American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4871.
Pełny tekst źródłaDoerr, F., S. Stange, A. Gassa, J. Seo, M. Heldwein, T. Wahlers i K. Hekmat. "It Is Worth Operating Small Cell Lung Cancer?" W 48th Annual Meeting German Society for Thoracic, Cardiac, and Vascular Surgery. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1678934.
Pełny tekst źródłaDias, Margarida, Raquel Marçoa, Rita Linhas, Sérgio Campainha, Sara Conde i Ana Barroso. "Non-small cell lung cancer in never-smokers". W ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2796.
Pełny tekst źródłaNeffati, O., L. Fekih, H. Kammoun, A. Ayari, I. Mejri, H. Smadhi, I. Akrout i in. "Prognostic factors in non-small cell lung cancer". W Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa4294.
Pełny tekst źródłaFu, Pin-Kuei. "Octogenarians With Operable Non-Small Cell Lung Cancer". W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4407.
Pełny tekst źródłaRaporty organizacyjne na temat "Small Cell Lung Cancer"
Freire, Mariana, Diana Martins, Maria Filomena Botelho i Fernando Mendes. Biomarkers of resistance mechanisms in innovative lung cancer treatments - A systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0011.
Pełny tekst źródłaWatson, Mark A. Genomic Characterization of Brain Metastasis in Non-Small Cell Lung Cancer Patients. Fort Belvoir, VA: Defense Technical Information Center, styczeń 2014. http://dx.doi.org/10.21236/ada606182.
Pełny tekst źródłaSage, Julien. Development of Antidepressants as Novel Agents To Treat Small Cell Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2014. http://dx.doi.org/10.21236/ada613784.
Pełny tekst źródłaRudin, Charles M. Genetic and Epigenetic Determinants of Lung Cancer Subtype: Adenocarcinoma to Small Cell Conversion. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2015. http://dx.doi.org/10.21236/ada623599.
Pełny tekst źródłaKang, Jing, Jun Zhang, Zongsheng Tian, Ye Xu, Jiangbi Li i Mingxina Li. The efficacy and safety of immune-checkpoint inhibitor plus chemotherapy versus chemotherapy for non-small cell lung cancer: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0156.
Pełny tekst źródłaNelkin, Barry D. Role of CDK5 as a Tumor Suppressor Gene in Non-Small Cell Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, sierpień 2014. http://dx.doi.org/10.21236/ada610950.
Pełny tekst źródłaYu, Guocan, Qingshan Cai, Xudong Xu, Yanqin Shen i Kan Xu. Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, styczeń 2021. http://dx.doi.org/10.37766/inplasy2021.1.0034.
Pełny tekst źródłaYu, Guocan, Qingshan Cai, Xudong Xu, Yanqin Shen i Kan Xu. Anlotinib-containing regimen for advanced small-cell lung cancer: A protocol of meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, styczeń 2021. http://dx.doi.org/10.37766/inplasy2021.1.0034.
Pełny tekst źródłaLi, Yong, Fang Yang i Ya-Yong Huang. Sublobar resection versus ablation for stage I non-small-cell lung cancer: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, styczeń 2021. http://dx.doi.org/10.37766/inplasy2021.1.0075.
Pełny tekst źródłaChen, Zhong-Ke, i Yuan-Shun Xu. I-125 seeds with chemotherapy for progressive non-small-cell lung cancer after first-line treatment. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2021. http://dx.doi.org/10.37766/inplasy2021.10.0120.
Pełny tekst źródła